These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 21463902

  • 1. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.
    Levine SZ, Rabinowitz J, Rizopoulos D.
    Psychiatry Res; 2011 Aug 15; 188(3):446-52. PubMed ID: 21463902
    [Abstract] [Full Text] [Related]

  • 2. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
    Levine SZ, Rabinowitz J.
    J Clin Psychopharmacol; 2007 Oct 15; 27(5):431-6. PubMed ID: 17873671
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J, Arango C, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group.
    J Clin Psychiatry; 2010 Mar 15; 71(3):280-6. PubMed ID: 19895779
    [Abstract] [Full Text] [Related]

  • 4. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.
    Kinon BJ, Ascher-Svanum H, Adams DH, Chen L.
    J Clin Psychopharmacol; 2008 Oct 15; 28(5):544-9. PubMed ID: 18794651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between insight and symptoms in schizophrenia.
    Sevy S, Nathanson K, Visweswaraiah H, Amador X.
    Compr Psychiatry; 2004 Oct 15; 45(1):16-9. PubMed ID: 14671732
    [Abstract] [Full Text] [Related]

  • 8. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M, Loza B.
    Psychiatr Pol; 2004 Oct 15; 38(5):795-808. PubMed ID: 15523927
    [Abstract] [Full Text] [Related]

  • 9. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 15; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 10. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
    Velligan DI, Alphs L, Lancaster S, Morlock R, Mintz J.
    Psychiatry Res; 2009 Sep 30; 169(2):97-100. PubMed ID: 19664826
    [Abstract] [Full Text] [Related]

  • 11. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP, Bossie CA, Lachaux B, Bouhours P, Zhu Y, Lasser R, Gharabawi GM.
    Int Clin Psychopharmacol; 2007 Jan 30; 22(1):51-5. PubMed ID: 17159460
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W.
    J Psychiatr Pract; 2008 Mar 30; 14(2):105-13. PubMed ID: 18360196
    [Abstract] [Full Text] [Related]

  • 13. The Positive and Negative Syndrome Scale--Spanish adaptation.
    Kay SR, Fiszbein A, Vital-Herne M, Fuentes LS.
    J Nerv Ment Dis; 1990 Aug 30; 178(8):510-7. PubMed ID: 2380697
    [Abstract] [Full Text] [Related]

  • 14. Psychotic symptoms in patients with bipolar mania.
    Canuso CM, Bossie CA, Zhu Y, Youssef E, Dunner DL.
    J Affect Disord; 2008 Dec 30; 111(2-3):164-9. PubMed ID: 18378001
    [Abstract] [Full Text] [Related]

  • 15. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Dec 30; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 16. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
    Moukas G, Stathopoulou A, Gourzis P, Beratis IN, Beratis S.
    Compr Psychiatry; 2010 Dec 30; 51(1):1-7. PubMed ID: 19932819
    [Abstract] [Full Text] [Related]

  • 17. Testosterone in first-episode schizophrenia.
    Cesková E, Prikryl R, Kaspárek T.
    Neuro Endocrinol Lett; 2007 Dec 30; 28(6):811-4. PubMed ID: 18063925
    [Abstract] [Full Text] [Related]

  • 18. To what extent do the PANSS and CGI-S overlap?
    Rabinowitz J, Mehnert A, Eerdekens M.
    J Clin Psychopharmacol; 2006 Jun 30; 26(3):303-7. PubMed ID: 16702895
    [Abstract] [Full Text] [Related]

  • 19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 30; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 20. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
    Ruhé HG, Dekker JJ, Peen J, Holman R, de Jonghe F.
    Compr Psychiatry; 2005 Dec 30; 46(6):417-27. PubMed ID: 16275208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.